The Clorox Company (NYSE:CLX) Shares Purchased by Mizuho Markets Americas LLC

Mizuho Markets Americas LLC boosted its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 3.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 43,870 shares of the company’s stock after purchasing an additional 1,315 shares during the period. Mizuho Markets Americas LLC’s holdings in Clorox were worth $7,147,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in CLX. Archer Investment Corp grew its holdings in shares of Clorox by 4,023.4% during the 3rd quarter. Archer Investment Corp now owns 2,639 shares of the company’s stock worth $430,000 after purchasing an additional 2,575 shares during the period. Empirical Finance LLC lifted its position in Clorox by 2.2% during the third quarter. Empirical Finance LLC now owns 4,274 shares of the company’s stock valued at $696,000 after buying an additional 93 shares in the last quarter. CIBC Asset Management Inc grew its stake in Clorox by 6.7% during the third quarter. CIBC Asset Management Inc now owns 21,144 shares of the company’s stock worth $3,445,000 after buying an additional 1,332 shares during the period. OneDigital Investment Advisors LLC acquired a new position in shares of Clorox during the 3rd quarter valued at $207,000. Finally, Huntington National Bank boosted its position in Clorox by 4.2% during the 3rd quarter. Huntington National Bank now owns 13,786 shares of the company’s stock worth $2,246,000 after purchasing an additional 559 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on the company. BNP Paribas upgraded Clorox to a “strong sell” rating in a research note on Friday, September 6th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and boosted their target price for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. DA Davidson lifted their target price on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Evercore ISI dropped their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Five analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, Clorox has an average rating of “Hold” and a consensus price target of $155.00.

Read Our Latest Stock Analysis on Clorox

Clorox Trading Up 1.2 %

Shares of NYSE:CLX opened at $167.69 on Friday. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The company’s 50-day moving average price is $162.45 and its 200 day moving average price is $147.47. The company has a market cap of $20.76 billion, a PE ratio of 58.43, a P/E/G ratio of 3.06 and a beta of 0.41. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $169.09.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the previous year, the firm posted $0.49 earnings per share. The business’s revenue was up 27.0% on a year-over-year basis. Sell-side analysts anticipate that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.91%. The ex-dividend date was Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is 170.04%.

Insider Activity at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. The trade was a 11.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 0.57% of the company’s stock.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.